Scientist wins whistleblower suit against Pfizer 
By:
Correy Stephenson
Published: April 19, 2010
Tags: Pfizer, virus
A U.S. District Court jury has awarded $1.37 million to a former Pfizer scientist who says she was exposed to a virus designed at the company’s labs in Groton, Conn.
Jurors in Neurontin trial hear opening arguments
By:
Nora Tooher
Published: March 31, 2010
Tags: Neurontin, off-label uses, Pfizer
BOSTON – Plaintiffs’ lawyer Ronald Rosenkranz urged jurors Wednesday to hold Pfizer Inc. liable for the death of Hartley Shearer, who committed suicide in 2002 after taking Neurontin for 16 months.
Jury selection begins in Neurontin suicide trial
By:
Nora Tooher
Published: March 29, 2010
Tags: Neurontin, off-label uses, Pfizer
BOSTON – Jury selection began Monday in the second wrongful death trial alleging Pfizer’s off-label promotion of its anti-epilepsy drug Neurontin caused a patient to commit suicide.
Pfizer ordered to pay $142M for Neurontin marketing fraud
By:
Nora Tooher
Published: March 26, 2010
Tags: Kaiser, Neurontin, off-label uses, Pfizer
BOSTON – A federal jury Thursday found that Pfizer violated anti-racketeering laws in promoting its epilepsy drug Neurontin for unapproved uses and must pay at least $142 million in damages.
Prempro litigation slugfest continues
By:
Nora Tooher
Published: February 26, 2010
Tags: hormone replacement therapy, HRT litigation, Pfizer, Prempro, Wyeth
The Prempro litigation in Philadelphia is turning into a Rocky-style slugfest, with both sides vowing to continue fighting it out in court.
NY judge dismisses 23 HRT lawsuits
By:
Nora Tooher
Published: December 22, 2009
Tags: hormone replacement therapy, Pfizer, Prempro, Wyeth
A New York trial court judge has dismissed lawsuits brought by 23 women who claim hormone replacement therapy drugs manufactured by Wyeth caused them to develop breast cancer.
Jury awards $34.3M against hormone therapy drug makers
By:
Kimberly Atkins
Published: November 24, 2009
Tags: hormone replacement therapy, Pfizer, Prempro, Wyeth
In one of two hefty verdicts within a month, a Pennsylvania jury handed down a $34 million award against Pfizer, finding that the drug maker willfully failed to warn patients of cancer risks associated with the hormone replacement drugs Premarin, Provera and Prempro.
Punitives in 1st HRT trial sealed; more verdicts soon
By:
Nora Tooher
Published: October 30, 2009
Tags: federal preemption, hormone replacement therapy, Pfizer, Prempro, Wyeth
After several years of delays, hormone-replacement litigation is moving forward, with one trial completed in Philadelphia and a second under way.
NEW FREE WHITE PAPER: E-Discovery
This FREE e-report brought to you by Lawyers USA contains the latest tips for conducting thorough and successful electronic discovery for your trial in 2012. We’ve analyzed the latest court rulings and trends in e-discovery to help you and your clients avoid sanctions and win your case.
Click here to get your free White Paper today!
